IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries Marks major milestone prior to launch in U.S. marketPressureSafe™ scanner and disposable pack both listed with FDAPressureSafe™ can support early detection of pressure injuries, potentially setting a...

IR-MED Appoints Richard Serbin, Esq. to its Advisory Board Served as Chief FDA Counsel for Revlon and Johnson & Johnson, as a Board Member at Johnson & Johnson Development Corporation, that company’s strategic venture capital division, and as patent...

IR-Med to present at National Pressure Injury Advisory Panel 2023 The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- “IR-MED” or the...

IR-Med Announces Dr. David Dalton as Advisory Board member Dr. Dalton brings decades of experience as a hall of fame CEO, entrepreneur, pharmaceutical executive and founder of over 40 companies Rosh Pinna, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) --...

IR-Med files Provisional Patent Application Covering Additional Features of its PressureSafe Device for Early Detection of Pressure Injuries Rosh Pinna, Israel, Aug. 12, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative medical device company, developing non-invasive, real-time detection devices that utilize...